Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel S. Lorrain currently holds 139,372 shares of Contineum Therapeutics, Inc. (CTNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel S. Lorrain has been a net seller of CTNM stock. They have purchased $0 and sold $224.5K worth of shares.
Daniel S. Lorrain's most recent insider trade was on Jun 1, 2026, when they sold 4,170 shares at $13.16 per share.
Daniel S. Lorrain serves as Executive at Contineum Therapeutics, Inc. (CTNM). They have executed 6 insider transactions totaling $224.5K over their tenure at the company.
Daniel S. Lorrain holds the position of Executive at Contineum Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Daniel S. Lorrain has shown a selling trading pattern, with $0 in total purchases and $224.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel S. Lorrain was on Mar 2, 2026, when they sold $62.6K worth of CTNM shares. This transaction involved 4,170 shares at $15.01 per share.
Daniel S. Lorrain currently owns 139,372 shares of Contineum Therapeutics, Inc. (CTNM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel S. Lorrain's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel S. Lorrain has 6 Form 4 filings on record as an insider at Contineum Therapeutics, Inc..
Set alerts for Daniel S. Lorrain and 40,000+ other insiders.